Analysts predict that Acadia Healthcare Company, Inc. (NASDAQ:ACHC) will report earnings of $0.69 per share for the current quarter, Zacks Investment Research reports. Four analysts have made estimates for Acadia Healthcare’s earnings. The highest EPS estimate is $0.72 and the lowest is $0.66. Acadia Healthcare reported earnings per share of $0.51 in the same quarter last year, which would suggest a positive year-over-year growth rate of 35.3%. The company is expected to issue its next earnings report after the market closes on Thursday, February 25th.
On average, analysts expect that Acadia Healthcare will report full-year earnings of $2.33 per share for the current financial year, with EPS estimates ranging from $2.30 to $2.36. For the next financial year, analysts anticipate that the firm will report earnings of $2.58 per share, with EPS estimates ranging from $2.42 to $2.69. Zacks’ EPS averages are a mean average based on a survey of sell-side analysts that follow Acadia Healthcare.
A number of research firms recently commented on ACHC. Zacks Investment Research downgraded Acadia Healthcare from a “hold” rating to a “sell” rating and set a $56.00 price objective on the stock. in a report on Thursday, February 11th. Robert W. Baird reiterated a “neutral” rating on shares of Acadia Healthcare in a report on Thursday, December 31st. Stephens increased their price target on Acadia Healthcare from $33.00 to $42.00 and gave the company an “equal weight” rating in a report on Monday, November 2nd. Credit Suisse Group increased their price target on Acadia Healthcare from $36.00 to $44.00 in a report on Thursday, December 31st. Finally, Jefferies Financial Group increased their price target on Acadia Healthcare from $44.00 to $60.00 and gave the company a “buy” rating in a report on Wednesday, December 30th. They noted that the move was a valuation call. One research analyst has rated the stock with a sell rating, six have given a hold rating, three have issued a buy rating and one has assigned a strong buy rating to the company. The company currently has a consensus rating of “Hold” and a consensus target price of $45.80.
Several institutional investors have recently made changes to their positions in ACHC. Point72 Hong Kong Ltd bought a new position in Acadia Healthcare in the third quarter worth $26,000. Nisa Investment Advisors LLC bought a new position in Acadia Healthcare in the fourth quarter worth $35,000. Eudaimonia Partners LLC bought a new position in Acadia Healthcare in the third quarter worth $92,000. Captrust Financial Advisors lifted its position in Acadia Healthcare by 13.9% in the third quarter. Captrust Financial Advisors now owns 4,823 shares of the company’s stock worth $145,000 after purchasing an additional 590 shares during the period. Finally, Great West Life Assurance Co. Can lifted its position in Acadia Healthcare by 71.0% in the third quarter. Great West Life Assurance Co. Can now owns 76,600 shares of the company’s stock worth $196,000 after purchasing an additional 31,813 shares during the period.
Acadia Healthcare Company Profile
Acadia Healthcare Company, Inc develops and operates inpatient psychiatric facilities, residential treatment centers, group homes, substance abuse facilities, and outpatient behavioral healthcare facilities to serve the behavioral health and recovery needs of communities in the United States, the United Kingdom, and Puerto Rico.
See Also: Capital Gains Distribution
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.